The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
Clinical trial NCT03502902 · COMPLETED
Trial details
- NCT number
- NCT03502902
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2019-03-15
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.